These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 22327697)

  • 1. Normal hypocretin-1 (orexin A) levels in cerebrospinal fluid in patients with idiopathic intracranial hypertension.
    Poca MA; Galard R; Serrano E; Merino MA; Pozo-Rosich P; Solana E; Mestres O; de la Calzada MD; Sahuquillo J
    Acta Neurochir Suppl; 2012; 114():221-5. PubMed ID: 22327697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid hypocretin-1 levels during the active period of cluster headache.
    Cevoli S; Pizza F; Grimaldi D; Nicodemo M; Favoni V; Pierangeli G; Valko PO; Baumann CR; Montagna P; Bassetti CL; Cortelli P
    Cephalalgia; 2011 Jun; 31(8):973-6. PubMed ID: 21444644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased cerebrospinal fluid hypocretin-1 (orexin A) in patients after repetitive generalized tonic-clonic seizures.
    Rejdak K; Papuć E; Grieb P; Stelmasiak Z
    Epilepsia; 2009 Jun; 50(6):1641-4. PubMed ID: 19175390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CSF orexin-A/hypocretin-1 concentrations in patients with intracerebral hemorrhage (ICH).
    Dohi K; Ripley B; Fujiki N; Ohtaki H; Yamamoto T; Goto Y; Nakamachi T; Shioda S; Aruga T; Nishino S
    Regul Pept; 2008 Jan; 145(1-3):60-4. PubMed ID: 17868933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal cerebrospinal fluid levels of hypocretin-1 (orexin A) in patients with fibromyalgia syndrome.
    Taiwo OB; Russell IJ; Mignot E; Lin L; Michalek JE; Haynes W; Xiao Y; Zeitzer JM; Larson AA
    Sleep Med; 2007 Apr; 8(3):260-5. PubMed ID: 17369087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal CSF hypocretin-1 (orexin A) levels in dementia with Lewy bodies associated with excessive daytime sleepiness.
    Baumann CR; Dauvilliers Y; Mignot E; Bassetti CL
    Eur Neurol; 2004; 52(2):73-6. PubMed ID: 15256827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid hypocretin-1 levels in multiple system atrophy.
    Martinez-Rodriguez JE; Seppi K; Cardozo A; Iranzo A; Stampfer-Kountchev M; Wenning G; Tolosa E; Högl B; Santamaria J; Poewe W;
    Mov Disord; 2007 Sep; 22(12):1822-4. PubMed ID: 17659646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum and CSF vitamin A concentrations in idiopathic intracranial hypertension.
    Tabassi A; Salmasi AH; Jalali M
    Neurology; 2005 Jun; 64(11):1893-6. PubMed ID: 15955940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF orexin levels of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degeneration.
    Yasui K; Inoue Y; Kanbayashi T; Nomura T; Kusumi M; Nakashima K
    J Neurol Sci; 2006 Dec; 250(1-2):120-3. PubMed ID: 17005202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanin concentrating hormone in central hypersomnia.
    Peyron C; Valentin F; Bayard S; Hanriot L; Bedetti C; Rousset B; Luppi PH; Dauvilliers Y
    Sleep Med; 2011 Sep; 12(8):768-72. PubMed ID: 21697009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relation of brain ouabain-like compounds and idiopathic intracranial hypertension.
    Borsody M; Semenov I; Carroll K; Kessler A; Dubow J; Olson E; Stern J; Barion A; Hammond C; Van Stavern G; Raizer J; White R; Leenen F
    Headache; 2006 Sep; 46(8):1255-60. PubMed ID: 16942469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of corticotrophin-releasing factor and orexin-A in chronic migraine and medication-overuse headache: findings from cerebrospinal fluid.
    Sarchielli P; Rainero I; Coppola F; Rossi C; Mancini M; Pinessi L; Calabresi P
    Cephalalgia; 2008 Jul; 28(7):714-22. PubMed ID: 18479471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSF hypocretin-1/orexin-A concentrations in patients with subarachnoid hemorrhage (SAH).
    Dohi K; Ripley B; Fujiki N; Ohtaki H; Shioda S; Aruga T; Nishino S
    Peptides; 2005 Nov; 26(11):2339-43. PubMed ID: 15893406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF hypocretin-1 levels are normal in patients with amyotrophic lateral sclerosis.
    Van Rooij FG; Schelhaas HJ; Lammers GJ; Verbeek MM; Overeem S
    Amyotroph Lateral Scler; 2009; 10(5-6):487-9. PubMed ID: 19922146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinol-binding protein and retinol analysis in cerebrospinal fluid and serum of patients with and without idiopathic intracranial hypertension.
    Warner JE; Larson AJ; Bhosale P; Digre KB; Henley C; Alder SC; Katz BJ; Bernstein PS
    J Neuroophthalmol; 2007 Dec; 27(4):258-62. PubMed ID: 18090557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A patient with anti-aquaporin 4 antibody who presented with recurrent hypersomnia, reduced orexin (hypocretin) level, and symmetrical hypothalamic lesions.
    Nozaki H; Shimohata T; Kanbayashi T; Sagawa Y; Katada S; Satoh M; Onodera O; Tanaka K; Nishizawa M
    Sleep Med; 2009 Feb; 10(2):253-5. PubMed ID: 18226957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSF hypocretin-1 concentrations correlate with the level of fatigue in multiple sclerosis patients.
    Papuć E; Stelmasiak Z; Grieb P; Paweł G; Rejdak K
    Neurosci Lett; 2010 Apr; 474(1):9-12. PubMed ID: 20193740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal hypocretin-1 (orexin-A) levels in the cerebrospinal fluid of patients with Huntington's disease.
    Meier A; Mollenhauer B; Cohrs S; Rodenbeck A; Jordan W; Meller J; Otto M
    Brain Res; 2005 Nov; 1063(2):201-3. PubMed ID: 16263095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased orexin levels in the cerebrospinal fluid the first year after a suicide attempt.
    Brundin L; Björkqvist M; Träskman-Bendz L; Petersén A
    J Affect Disord; 2009 Feb; 113(1-2):179-82. PubMed ID: 18533274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between clinical characteristics of narcolepsy and CSF orexin-A levels.
    Nakamura M; Kanbayashi T; Sugiura T; Inoue Y
    J Sleep Res; 2011 Mar; 20(1 Pt 1):45-9. PubMed ID: 20642748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.